2. Academic Validation
  3. Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells

Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells

  • J Med Chem. 2015 Mar 12;58(5):2206-20. doi: 10.1021/jm501518y.
Alexander V Aksenov 1,  Alexander N Smirnov,  Igor V Magedov,  Mary R Reisenauer,  Nicolai A Aksenov,  Inna V Aksenova,  Alexander L Pendleton,  Gina Nguyen,  Robert K Johnston,  Michael Rubin,  Annelise De Carvalho,  Robert Kiss,  Véronique Mathieu,  Florence Lefranc,  Jaime Correa,  David A Cavazos,  Andrew J Brenner,  Brad A Bryan,  Snezna Rogelj,  Alexander Kornienko,  Liliya V Frolova
Affiliations

Affiliation

  • 1 Department of Chemistry, North Caucasus Federal University , 1a Pushkin St., Stavropol 355009, Russian Federation.
PMID: 25671501 DOI: 10.1021/jm501518y
Abstract

Many types of tumor, including glioma, melanoma, non-small cell lung, esophageal, and head and neck Cancer, among Others, are intrinsically resistant to Apoptosis induction and poorly responsive to current therapies with proapoptotic agents. In addition, tumors often develop multidrug resistance based on the cellular efflux of chemotherapeutic agents. Thus, novel Anticancer agents capable of overcoming these intrinsic or developed tumor resistance mechanisms are urgently needed. We describe a series of 2-aryl-2-(3-indolyl)acetohydroxamic acids that are active against apoptosis- and multidrug-resistant Cancer cells as well as glioblastoma neurosphere stemlike cell cultures derived from patients. Thus, the described compounds serve as a novel chemical scaffold for the development of potentially highly effective clinical Cancer drugs.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z